top of page

Bridging Innovation and Policy: SILREAL at the European China Conference 2024

At the European China Conference 2024, hosted by MERICS and the European Council on Foreign Relations, SILREAL's CEO, Chenchao Liu, played a pivotal role in shaping discussions on the transformative potential of biotechnology and global innovation. 

Approach

SILREAL's participation in the European China Conference 2024 was centered on its expertise in fostering cross-border collaboration in healthcare and life sciences. As part of the breakout session titled “Transformative Power: China’s Approach to Biotech,” SILREAL offered a comprehensive analysis of how biotechnology, artificial intelligence, and strategic investments are reshaping global innovation.

During the session, SILREAL illuminated the rapid advancements in China’s biotech sector, emphasizing how policy-driven innovation has positioned the country as a global leader. A significant focus was placed on artificial intelligence, which has become a cornerstone of modern drug discovery, with 31% of global funding directed toward AI-powered solutions in China. This trend was presented as both a challenge and an opportunity for Europe, highlighting the importance of adopting similar strategies to remain competitive.

SILREAL also provided recommendations for Europe to strengthen its biotechnology sector. These included prioritizing investments in biomolecules, biocomputing, and AI technologies, while also fostering collaborations that integrate cross-border insights. SILREAL emphasized the value of bridging regulatory and cultural gaps to facilitate seamless collaboration between European and Chinese stakeholders.

Konferenz
Arzt mit Tablet

Result

SILREAL's contributions to the conference were widely recognized for their depth and relevance, significantly enhancing the quality of discussions. The insights shared offered concrete strategies for European stakeholders to leverage advancements in biotechnology and align investments with global trends.

The conference provided a platform for SILREAL to facilitate meaningful dialogue between European and Chinese experts, strengthening cross-border partnerships in biotechnology and healthcare innovation. These discussions laid the foundation for actionable collaboration, enabling more effective alignment of policies and strategies.

Through its strategic participation, SILREAL reaffirmed its role as a thought leader and trusted partner in driving cross-border innovation. The connections and insights gained during the event have set the stage for continued collaboration, fostering future advancements in healthcare and life sciences.

bottom of page